Hangzhou Alltest Biotech Co., Ltd. (688606.SS) — Stock Score Summary

Hangzhou Alltest Biotech Co., Ltd. (688606.SS) has a MoatMap StockRank of 59/100 based on Quality (63/100), Value (54/100), and Momentum (27/100) factor scores. The current signal is HOLD. Hangzhou Alltest Biotech operates in a highly commoditized in-vitro diagnostics market with declining post-pandemic demand and lacks the proprietary platform or regulatory moat of a high-value CDMO.

Hangzhou Alltest Biotech Co., Ltd. develops and manufactures rapid diagnostic test kits, specializing in lateral flow immunoassay technology for infectious diseases, drug abuse, and oncology. The company is highly export-oriented, holding numerous international regulatory approvals including US FDA, CE mark, and WHO prequalification. Its competitive advantage lies in its low-cost manufacturing base, extensive global distribution network, and rapid development cycle for emerging pathogens.

Key Financial Metrics

Price$6.97
Market Cap$556M
P/E (TTM)22.07
Price/Book0.99
Return on Equity4.5%
Return on Invested Capital6.4%
Debt/Equity0.19
Gross Margin49.8%
Operating Margin15.4%
Revenue Growth-6.3%
Dividend Yield4.1%
Free Cash Flow$-1M

Hangzhou Alltest Biotech Co., Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hangzhou Alltest Biotech Co., Ltd.’s (688606.SS) StockRank?
MoatMap’s StockRank for Hangzhou Alltest Biotech Co., Ltd. (688606.SS) is 59/100, with a Hold signal. It is a composite of Quality (63), Value (54), and Momentum (27) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hangzhou Alltest Biotech Co., Ltd. have an economic moat?
Hangzhou Alltest Biotech Co., Ltd. (688606.SS) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hangzhou Alltest Biotech Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Hangzhou Alltest Biotech Co., Ltd. (688606.SS) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hangzhou Alltest Biotech Co., Ltd. in?
Hangzhou Alltest Biotech Co., Ltd. (688606.SS) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (China).
Browse all ranked stocks688606.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock